Molecular Imaging of p53 in Mouse Models of Cancer Using a Radiolabeled Antibody TAT Conjugate with SPECT.
Alakonya H. et al, (2024), J Nucl Med
In Vivo PET Detection of Lung Micrometastasis in Mice by Targeting Endothelial VCAM-1 Using a Dual-Contrast PET/MRI Probe.
Melemenidis S. et al, (2024), Int J Mol Sci, 25
[123I]CC1: A PARP-Targeting, Auger Electron-Emitting Radiopharmaceutical for Radionuclide Therapy of Cancer.
Chan CY. et al, (2023), J Nucl Med, 64, 1965 - 1971
Correlation between molar activity, injection mass and uptake of the PARP targeting radiotracer [18F]olaparib in mouse models of glioma.
Chan CY. et al, (2022), EJNMMI Res, 12
Imaging PARP with [18F]rucaparib in pancreatic cancer models.
Chan CY. et al, (2022), Eur J Nucl Med Mol Imaging, 49, 3668 - 3678
Radiofluorination of a highly potent ATM inhibitor as a potential PET imaging agent.
Fraser CR. et al, (2022), EJNMMI Res, 12
Know thy tumour: Biomarkers to improve treatment of molecular radionuclide therapy.
O'Neill E. and Cornelissen B., (2022), Nucl Med Biol, 108-109, 44 - 53
PARP Inhibitors in Cancer Diagnosis and Therapy.
Chan CY. et al, (2021), Clin Cancer Res, 27, 1585 - 1594
Emerging chelators for nuclear imaging.
CORNELISSEN B. and SNEDDON D., (2021), Current Opinion in Chemical Biology
A Model System to Explore the Detection Limits of Antibody-Based Immuno-SPECT Imaging of Exclusively Intranuclear Epitopes
Veal M. et al, (2021), Journal of Nuclear Medicine
Combination Strategies to Improve Targeted Radionuclide Therapy.
Chan TG. et al, (2020), J Nucl Med, 61, 1544 - 1552
Exploring the limits of intranuclear PET/SPECT imaging with IgG-TAT: how low can you go?
Veal M. et al, (2020), EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 47, S78 - S78
Imaging tumour CD8+T-cell infiltrates following radioimmunotherapy in an immunocompetent mouse model
Cornelissen B. et al, (2020), EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 47, S162 - S163
Ratiometric relationship between gamma H2AX imaging and Lutetium-177 is predictive of survival following radionuclide therapy in vivo
O'Neill E. et al, (2020), EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 47, S54 - S55
Development of [18F]ICMT-11 for Imaging Caspase-3/7 Activity during Therapy-Induced Apoptosis.
García-Argüello SF. et al, (2020), Cancers (Basel), 12
Radiolabeled cCPE Peptides for SPECT Imaging of Claudin-4 Overexpression in Pancreatic Cancer.
Baguña Torres J. et al, (2020), J Nucl Med
A screen of 350 combination therapies with Lu-177-DOTATATE reveal distinct differences to EBRT and novel action of CDK4/6 inhibitors
ONeill E. et al, (2020), JOURNAL OF NUCLEAR MEDICINE, 61
Radiolabelled cCPE mutants allow selective imaging of claudin-4 in mouse models of PDAC
BAGUNA TORRES J. et al, (2020), The Journal of Nuclear Medicine
[18F]AZD2461, an insight on difference in PARP binding profiles for DNA damage response PET imaging
GUIBBAL F. et al, (2020), Molecular Imaging and Biology